AGP Executive Report
Last update: 6 hours agoMedicare GLP-1 access: CMS’s new “GLP-1 Bridge” pilot (starting July 1) lets eligible Medicare enrollees qualify for weight-loss drugs with a $50 monthly copay, using BMI and health-condition criteria plus prior authorization. Medicaid paperwork pressure: A new analysis warns that Medicaid “still eligible” renewals can still kick people off due to missed notices and documentation gaps, even when income hasn’t changed. Pharma legal fallout: Glenmark reached a nearly $30M settlement with Oregon and other states over alleged price-inflation and competition limits, with possible compensation for certain buyers. Hospital leadership moves: University of Vermont Health named Marc Kosak president and COO of Central Vermont Medical Center, aiming to boost access, quality, and workforce development. Pharmacy operations tech: TJM Labs launched “Vaccine Bot” to automate vaccination admin steps in pharmacies while keeping pharmacists in control. Global health & conflict: Israeli strikes in Gaza killed at least five Palestinians, according to medics and health officials. Clinical innovation: Clearmind Medicine reported improved intranasal MEAI nasal retention in ex vivo results, targeting Alcohol Use Disorder treatment delivery.
Note: AI summary from news headlines; neutral sources weighted more to help reduce bias in the result. Feedback is welcome. Please let us know if you have any comments or suggestions about the AGP Executive Report.
Perspectify News
